Displaying Tetra-Membrane Spanning Claudins on Enveloped Virus-Like Particles for Cancer Immunotherapy

Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines

(2016) O. Tu reci et al.   CLINICAL CANCER RESEARCH

Mutanome directed cancer immunotherapy

(2016) Mathias Vormehr et al.   CURRENT OPINION IN IMMUNOLOGY

Systems Proteomics View of the Endogenous Human Claudin Protein Family

(2016) Fei Liu et al.   JOURNAL OF PROTEOME RESEARCH

The application of virus-like particles as vaccines and biological vehicles

(2015) Dan Yan et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Therapeutic cancer vaccines

(2015) Cornelis J.M. Melief et al.   JOURNAL OF CLINICAL INVESTIGATION

Synthetic biology design to display an 18kDa rotavirus large antigen on a modular virus-like particle

(2015) Linda H.L. Lua et al.   VACCINE

Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer

(2014) Patrick Micke et al.   INTERNATIONAL JOURNAL OF CANCER

Crystal Structure of a Claudin Provides Insight into the Architecture of Tight Junctions

(2014) H. Suzuki et al.   SCIENCE

Hepatitis B core–based virus–like particles to present heterologous epitopes

(2013) Kenny Roose et al.   Expert Review of Vaccines

Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

(2013) Peter Pushko et al.   INTERVIROLOGY

Phage selection of bicyclic peptides

(2013) Inmaculada Rentero Rebollo et al.   METHODS

Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development

(2012) Natasha Kushnir et al.   VACCINE

Highly Specific Auto-Antibodies against Claudin-18 Isoform 2 Induced by a Chimeric HBcAg Virus-Like Particle Vaccine Kill Tumor Cells and Inhibit the Growth of Lung Metastases

(2011) Thorsten Klamp et al.   CANCER RESEARCH

Developments in virus-like particle-based vaccines for infectious diseases and cancer

(2011) Luigi Buonaguro et al.   Expert Review of Vaccines

HIV-1 Assembly Differentially Alters Dynamics and Partitioning of Tetraspanins and Raft Components

(2010) Dimitry N. Krementsov et al.   TRAFFIC

The state of the art: immune-mediated mechanisms of monoclonal antibodies in cancer therapy

(2009) J Griggs et al.   BRITISH JOURNAL OF CANCER

Vaccination with A -Displaying Virus-Like Particles Reduces Soluble and Insoluble Cerebral A  and Lowers Plaque Burden in APP Transgenic Mice

(2009) P. Bach et al.   JOURNAL OF IMMUNOLOGY

DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies

(2009) Bertrand Bellier et al.   VACCINE

Genetic targeting of the endoderm with claudin-6CreER

(2008) William J. Anderson et al.   DEVELOPMENTAL DYNAMICS

Monoclonal Antibodies in Cancer Therapy: 25 Years of Progress

(2008) Robert K. Oldham et al.   JOURNAL OF CLINICAL ONCOLOGY